lecanemab
-
Health News
Eisai files for approval of Alzheimer’s drug in Japan
Bengaluru: Japanese drugmaker Eisai Co Ltd said on Monday it had submitted a marketing authorization application in Japan for its Alzheimer’s drugs lecanemabwhich was recently…
Read More » -
Health News
Eisai, Biogen receive US FDA approval for Alzheimer’s drug, applies for full approval Health News ET HealthWorld
New Delhi: The US Food and Drug Administration on Friday approved the Alzheimer’s drug lecanemab developed by Eisai Co Ltd Biogen Inc for patients in…
Read More » -
Health News
Eisai Alzheimer’s drug and clot buster seen as cause of brain haemorrhage death, Health News, ET HealthWorld
Tokyo: Emergency treatment with a blood clot buster called tissue plasminogen activator for a patient who had a stroke while being treated with the experimental…
Read More » -
Health News
Eisai, Biogen’s new Alzheimer’s drug should be priced below Aduhelm
Bengaluru: An influential drug pricing research group said Eisai Co Ltd and Biogen Inc’s new Alzheimer’s disease treatment lecanemab should be priced lower than the…
Read More » -
Health News
Japan drugmaker Eisai’s shares slump after report of 3rd death in Alzheimer’s trial
Tokyo: Eisai Co. slid as much as six and a half percent in Tokyo trading on Friday after a report of a third death in…
Read More » -
Health News
Sysmex says Japan approves blood test for Alzheimer’s marker
Tokyo: Japan’s Sysmex Corp. said on Thursday that it had received regulatory approval in Japan for a blood test to detect amyloid beta in the…
Read More » -
Health News
Eisai shares plunge in Tokyo after report of death in Alzheimer’s trial
Tokyo: Shares in Japanese drugmaker Eisai Co fell more than 6 percent on Tuesday after a report that a woman in a trial of the…
Read More » -
Health News
Eisai, Biogen say Alzheimer’s drug succeeds in slowing cognitive decline, Health News, ET HealthWorld
Eisai Co Ltd and Biogen Inc on Tuesday said their experimental Alzheimer’s drug significantly slowed cognitive and functional decline in a large trial of patients…
Read More »